Chicago, Feb. 4 – Orexo AB (publ.) sold SEK 500 million of senior callable floating-rate notes with an interest rate based on Stibor plus 375 basis points and a maturity in February 2025, according to a press release.
The issue was oversubscribed with interest from Nordic and international investors.
Proceeds will be used to repurchase SEK 77.4 million of the company’s outstanding senior callable floating-rate bonds. The company will call for early redemption of the residual amount of the existing bonds, SEK 148.5 million, in accordance with the terms and conditions of the bonds, additional information which will be provided separately.
ABG Sundal Collier AB was the financial adviser and bookrunner for the offering.
Orexo is a specialty pharmaceutical company based in Uppsala, Sweden.
| Issuer: | Orexo AB (publ.)
|
| Issue: | Senior callable floating-rate notes
|
| Amount: | SEK 500 million
|
| Maturity: | February 2025
|
| Bookrunner: | ABG Sundal Collier AB
|
| Coupon: | Stibor plus 375 bps
|
| Pricing date: | Feb. 4
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
